Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 2tremelimumab 1motexafin gadolinium 1lenvatinib 1ispinesib 1durvalumab 1X-Rays 1Specimen Handling 1Sorafenib 1Radiotherapy 1Radiosurgery 1Radiofrequency Ablation 1Platinum 1Phantoms, Imaging 1Ondansetron 1Mitomycin 1Interferon-alpha 1Gemcitabine 1Embolization, Therapeutic 1Doxorubicin 1Dexamethasone 1Cisplatin 1Capecitabine 1CF regimen 1Bone Density 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Hepatocellular × ispinesib × Clear all
NCT00095992 2023-08-04

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Canadian Cancer Trials Group

Phase 2 Completed
15 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡